For IP professionals
This is the portal for professionals working in the field of intellectual property. Here you'll find direct access to all necessary resources.
Quick links
- Trade Mark Database
- Register changes for trade marks
- Swissreg
- Madrid Monitor
- TMview
- E-trademark
- International trade mark registration
- Trade Mark Guidelines (German, French, Italian)
- Classification tool for trade marks
- Trade mark examination support tool
- Trade marks: Costs and fees
- Trade marks: WIPO fee calculator
- Cancellation procedure for trade marks on the grounds of non-use
- Protected public signs: Abbreviations
- Protected public signs: Other signs (emblems)
- Directory of Intellectual Property Offices
- Trade marks: News Service Archive
- Patents: Patent Examination Guidelines (German, French)
- Patents: Fees
News
Biotechnological inventions
Biotechnological inventions concern biological material. “Biological material” is a material that contains genetic information, is reproducible and is highly complex. In 2008, Switzerland adapted its patent legislation to the provisions of EU Directive 98/44/EC on the legal protection of biotechnological inventions in a comprehensive revision of the Patents Act.
A biotechnological invention can be patented if it meets the general requirements for patentability. This means that there must be an inventive step (not just a discovery) which is novel and not obvious, and it must be able to be commercially used.
The revised Patents Act not only ensures effective and appropriate protection for biotechnological inventions, it also defines the ethical limits of patentability. For example, the human body including embryos cannot be patented. The same applies for inventions that are contrary to public policy or public morality (such as methods to clone human beings).
In addition, the Patents Act defines exceptions to the effects of a patent. For instance, even without the permission of the patent holder, it is possible:
- to conduct scientific research on the invention (research exemption);
- to have free access to plant genetic material for research and further growth (breeder’s exemption);
- to have free access to the patented invention for teaching purposes;
- for farmers to reproduce the harvested material on their own farm (agricultural exemption).
The revised regulations ensure an appropriate balance between the interests of patent holders and those of the public at large in the area of biotechnology.
News
24.05.2022 | Patents, Trade Marks
A strategy for success – how a Swiss start-up protects its inventions
...more
18.05.2022 | Media release, IPI
Federal Council adopts strategic objectives for Swiss Federal Institute of Intellectual Property
...more
17.05.2022 | Patents, Trade Marks, Law and policy, Designs
Termination of the Agreement between Switzerland and Germany on Reciprocal Protection for Patents, Designs and Trade Marks
...more
Events
14.04.2022 | Patents, Event, IPI
EPO/IPI - invitation to a free public online seminar on patenting topics in green tech
...more
01.10.2021 | Event, Partners and initiatives, IPI
How SMEs protect their primary raw material – know-how
...more